Skip to content

A prospective clinical trial on MRD monitoring in patients with NMIBC scheduled for Re-TURBT based on urinary biomarkers

A prospective clinical trial on MRD monitoring in patients with NMIBC scheduled for Re-TURBT based on urinary biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107202
Enrollment
Unknown
Registered
2025-08-06
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Interventions

Index test:UI-Seek Multi-gene Combined Urine Testing

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed NMIBC patients; 2. Age >= 18 years old, regardless of gender; 3. Planning to undergo secondary ET; 4. Must provide sufficient urine samples after the first ET and before the second ET; 5. Able to sign the informed consent form, willing to abide by the agreement, good compliance, and cooperate with the follow-up of the participating center.

Exclusion criteria

Exclusion criteria: 1. Patients with relapsed NMIBC and then progressed to MIBC; 2. Lymph node metastasis or distant metastasis at the time of first visit; 3. History of other malignant tumors or any anticancer treatment within 5 years; 4. Combined with other genitourinary tumors (renal cancer or prostate cancer); 5. Participated in drug clinical trials within 3 months before enrollment; 6. Any situation that the researcher believes may increase the risk of the subjects or interfere with the implementation of the clinical trial; 7. Due to various reasons, the samples and clinical data are incomplete.

Design outcomes

Primary

MeasureTime frame
Negative Predictive Value;2-year event-free survival;

Countries

China

Contacts

Public ContactDingwei Ye

Fudan University Shanghai Cancer Center

wujunlong920601@163.com+86 137 0166 3571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026